Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery

Acta Derm Venereol. 2024 May 13:104:adv21502. doi: 10.2340/actadv.v104.21502.

Authors

Yasuaki Ikuno¹, Akihiko Yamaguchi², Toshifumi Takahashi¹, Noriki Fujimoto¹

Affiliations

¹ Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga, Japan.
² Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga, Japan. ymgch@belle.shiga-med.ac.jp.

No abstract available

Publication types

Case Reports

MeSH terms

BNT162 Vaccine / adverse effects
COVID-19 Vaccines / adverse effects
COVID-19 Vaccines / immunology
COVID-19* / immunology
COVID-19* / prevention & control
Female
Humans
Male
SARS-CoV-2 / immunology
Th1 Cells* / immunology
Th2 Cells* / immunology
Uveomeningoencephalitic Syndrome* / chemically induced
Uveomeningoencephalitic Syndrome* / diagnosis
Uveomeningoencephalitic Syndrome* / immunology

Substances

BNT162 Vaccine
COVID-19 Vaccines